PL367639A1 - Nowy związek heterocykliczny i jego zastosowanie w medycynie - Google Patents

Nowy związek heterocykliczny i jego zastosowanie w medycynie

Info

Publication number
PL367639A1
PL367639A1 PL02367639A PL36763902A PL367639A1 PL 367639 A1 PL367639 A1 PL 367639A1 PL 02367639 A PL02367639 A PL 02367639A PL 36763902 A PL36763902 A PL 36763902A PL 367639 A1 PL367639 A1 PL 367639A1
Authority
PL
Poland
Prior art keywords
heterocyclic compound
medicinal use
novel heterocyclic
novel
medicinal
Prior art date
Application number
PL02367639A
Other languages
English (en)
Inventor
Hiroshi Matsui
Hideo Kobayashi
Satoru Azukizawa
Masayasu Kasai
Akihisa Yoshimi
Hiroaki Shirahase
Original Assignee
Kyoto Pharmaceutical Industries, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharmaceutical Industries, Ltd. filed Critical Kyoto Pharmaceutical Industries, Ltd.
Publication of PL367639A1 publication Critical patent/PL367639A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL02367639A 2001-05-29 2002-05-27 Nowy związek heterocykliczny i jego zastosowanie w medycynie PL367639A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001161489 2001-05-29
PCT/JP2002/005097 WO2002096880A1 (en) 2001-05-29 2002-05-27 Novel heterocyclic compound and medicinal use thereof

Publications (1)

Publication Number Publication Date
PL367639A1 true PL367639A1 (pl) 2005-03-07

Family

ID=19004756

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367639A PL367639A1 (pl) 2001-05-29 2002-05-27 Nowy związek heterocykliczny i jego zastosowanie w medycynie

Country Status (22)

Country Link
US (1) US7557123B2 (pl)
EP (1) EP1403253A4 (pl)
JP (1) JP4279136B2 (pl)
KR (2) KR20040030647A (pl)
CN (1) CN1242994C (pl)
AR (1) AR036036A1 (pl)
AU (1) AU2002308889B2 (pl)
BR (1) BR0209711A (pl)
CA (1) CA2448634A1 (pl)
CO (1) CO5540342A2 (pl)
CZ (1) CZ20033450A3 (pl)
HU (1) HUP0401862A3 (pl)
IL (1) IL159085A0 (pl)
MX (1) MXPA03010811A (pl)
NO (1) NO326688B1 (pl)
NZ (1) NZ530358A (pl)
PL (1) PL367639A1 (pl)
RU (1) RU2299197C2 (pl)
TW (1) TWI297008B (pl)
WO (1) WO2002096880A1 (pl)
YU (1) YU94003A (pl)
ZA (1) ZA200309757B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100874677B1 (ko) 2001-05-29 2008-12-18 교토 야쿠힝 고교 가부시키가이샤 신규 복소환 유도체 및 그 의약 용도
US7816385B2 (en) * 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
US7718377B2 (en) 2003-05-29 2010-05-18 Kyoto Pharmaceutical Industries, Ltd. Insulin resistance curative and method of screening the same
TWI359810B (en) * 2004-11-04 2012-03-11 Mitsubishi Tanabe Pharma Corp Carboxylic acid derivative containing thiazole rin
US7790745B2 (en) 2005-10-21 2010-09-07 Bristol-Myers Squibb Company Tetrahydroisoquinoline LXR Modulators
WO2007058504A1 (en) * 2005-11-21 2007-05-24 Lg Life Sciences, Ltd. Novel compounds as agonist for ppar gamma and ppar alpha, method for preparation of the same, and pharmaceutical composition containing the same
RU2411936C2 (ru) * 2009-01-11 2011-02-20 Институт физиологии Коми научного центра Уральского отделения Российской академии наук. Государственное учреждение Применение 2-морфолино-5-фенил-6н-1,3,4-тиадизин, гидробромида в качестве средства, обладающего гиполипидемическим и гипергликемическим эффектом
WO2012033195A1 (ja) * 2010-09-10 2012-03-15 京都薬品工業株式会社 複素環化合物
CN102807526B (zh) * 2011-06-21 2015-12-02 寿光富康制药有限公司 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ｐｔｐ－１ｂ阻害剤およびその用途
EP4265258A4 (en) * 2020-12-18 2024-11-13 ASKA Pharmaceutical Co., Ltd. FIXED FORMULATION

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051189A (ja) 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
AR240698A1 (es) 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
ATE186724T1 (de) 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
US5246943A (en) * 1992-05-19 1993-09-21 Warner-Lambert Company Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
DE69731003D1 (de) * 1996-07-01 2004-11-04 Lilly Co Eli Blutzuckersenkende und lipidsenkende verbindungen
IL121202A (en) 1996-07-01 2001-08-26 Lilly Co Eli Hypoglycemic and hypolipidemic compounds, process for their preparation, pharmaceutial compositions comprising same, and uses thereof
GB9817118D0 (en) * 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
CZ20021911A3 (cs) 1999-12-03 2002-10-16 Kyoto Pharmaceutical Industries, Ltd. Nové heterocyklické sloučeniny a jejich soli a jejich vyuľití v lékařství
US20020037897A1 (en) 2000-08-07 2002-03-28 3-Dimensional Pharmaceuticals, Inc. Tetrahydroisoquinoline-3-carboxylic acid alkoxyguanidines as integrin antagonists
KR100874677B1 (ko) * 2001-05-29 2008-12-18 교토 야쿠힝 고교 가부시키가이샤 신규 복소환 유도체 및 그 의약 용도

Also Published As

Publication number Publication date
HUP0401862A2 (hu) 2004-12-28
KR100898358B1 (ko) 2009-05-20
EP1403253A1 (en) 2004-03-31
RU2003137574A (ru) 2005-05-20
YU94003A (sh) 2006-08-17
TWI297008B (en) 2008-05-21
CN1242994C (zh) 2006-02-22
CN1527819A (zh) 2004-09-08
HUP0401862A3 (en) 2009-03-30
BR0209711A (pt) 2004-11-03
MXPA03010811A (es) 2004-02-27
HK1069385A1 (en) 2005-05-20
JPWO2002096880A1 (ja) 2004-09-09
AR036036A1 (es) 2004-08-04
US20040220215A1 (en) 2004-11-04
NZ530358A (en) 2005-04-29
EP1403253A4 (en) 2005-03-30
CZ20033450A3 (cs) 2004-05-12
AU2002308889B2 (en) 2007-09-06
NO326688B1 (no) 2009-01-26
CA2448634A1 (en) 2002-12-05
ZA200309757B (en) 2004-12-22
KR20080093076A (ko) 2008-10-17
CO5540342A2 (es) 2005-07-29
NO20035331D0 (no) 2003-11-28
KR20040030647A (ko) 2004-04-09
US7557123B2 (en) 2009-07-07
RU2299197C2 (ru) 2007-05-20
WO2002096880A1 (en) 2002-12-05
IL159085A0 (en) 2004-05-12
JP4279136B2 (ja) 2009-06-17

Similar Documents

Publication Publication Date Title
HUP0402236A3 (en) Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
EP1571146A4 (en) NITROGENIC HETEROCYCLIC COMPOUNDS AND THEIR MEDICAL USE
EP1405859A4 (en) NITROGENIC HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, MEDICAL USE AND INTERMEDIATE PRODUCTS CONTAINING THEREOF
AU2003291310A1 (en) Fused heterocyclic compounds and use thereof
IL157740A0 (en) Heterocyclic derivatives and pharmaceutical compositions containing the same
GB0003254D0 (en) Heterocyclic compounds and their therapeutic use
PL367676A1 (pl) Nowe pochodne heterocykliczne i ich zastosowanie w medycynie
TWI315982B (en) Combinations comprising epothilones and pharmaceutical uses thereof
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
GB0105613D0 (en) Pharmaceutically effective compounds and their use
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
HUP0401862A3 (en) Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
HUP0303799A3 (en) 5-membered heterocycles and application thereof as medicaments
EP1683798A4 (en) NEW CONDENSED POLYCYCLIC COMPOUND WITH HETEROCYCLUS AND THEIR MEDICAL USE
GB0119025D0 (en) Compounds and their therapeutic use
GB0018887D0 (en) Compound and their therapeutic use
GB0024517D0 (en) Use of medicaments
EP1367123A4 (en) NEUROTONIN AND ITS USE
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
GB0128138D0 (en) Pharmaceutical use